A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer

International Journal of Colorectal Disease

Volumn 32, Issue 4, 2017, Pages 443-451

  Reynolds, Ian S ^a   O’Toole, Aobhlinn ^a   Deasy, Joseph ^a   McNamara, Deborah A ^a   Burke, John P ^a,b  

^a BEAUMONT HOSPITAL   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Clinicopathological characteristics; Colorectal cancer; Inflammatory bowel disease; Survival outcomes

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; COLORECTAL CANCER; DISTANT METASTASIS; HUMAN; HUMAN TISSUE; INFLAMMATORY BOWEL DISEASE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEX RATIO; TUMOR DIFFERENTIATION; COLORECTAL TUMOR; COMPLICATION; FEMALE; MALE; META ANALYSIS; PATHOLOGY; PUBLISHING; SURVIVAL ANALYSIS; TIME FACTOR; TREATMENT OUTCOME;

COLORECTAL NEOPLASMS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; PUBLICATION BIAS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 85009273490     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-017-2754-3     Document Type: Review

References (40)

1. Eaden JA, Abrams KR, Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48(4):526–535
2. Jess T, Rungoe C, Peyrin-Biroulet L (2012) Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 10(6):639–645
3. von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP (2007) The risk of cancer in patients with Crohn’s disease. Dis Colon rectum 50(6):839–855
4. Harpaz N, Peck AL, Yin J, Fiel I, Hontanosas M, Tong TR, Laurin JN, Abraham JM, Greenwald BD, Meltzer SJ (1994) p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma. Hum Pathol 25(10):1069–1074
5. Burmer GC, Levine DS, Kulander BG, Haggitt RC, Rubin CE, Rabinovitch PS (1990) c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology 99(2):416–420
6. Garrity-Park MM, Loftus EV Jr, Bryant SC, Sandborn WJ, Smyrk TC (2008) Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer. Am J Gastroenterol 103(2):407–415
7. Larsen M, Mose H, Gislum M, Skriver MV, Jepsen P, Nørgård B, Sørensen HT (2007) Survival after colorectal cancer in patients with Crohn’s disease: a nationwide population-based Danish follow-up study. Am J Gastroenterol 102(1):163–167
8. Jensen AB, Larsen M, Gislum M, Skriver MV, Jepsen P, Nørgaard B, Sørensen HT (2006) Survival after colorectal cancer in patients with ulcerative colitis: a nationwide population-based Danish study. Am J Gastroenterol 101(6):1283–1287
9. Aarnio M, Mustonen H, Mecklin JP, Järvinen HJ (1998) Prognosis of colorectal cancer varies in different high-risk conditions. Ann Med 30(1):75–80
10. Lavery IC, Chiulli RA, Jagelman DG, Fazio VW, Weakley FL (1982) Survival with carcinoma arising in mucosal ulcerative colitis. Ann Surg 195(4):508–512
11. Gyde SN, Prior P, Thompson H, Waterhouse JA, Allan RN (1984) Survival of patients with colorectal cancer complicating ulcerative colitis. Gut 25(3):228–231
12. Watanabe T, Konishi T, Kishimoto J, Kotake K, Muto T, Sugihara K (2011) Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study. Inflamm Bowel Dis 17(3):802–808
13. Delaunoit T, Limburg PJ, Goldberg RM, Lymp JF, Loftus EV (2006) Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 4(3):335–342
14. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB, Meta-analysis of Observational Studies in Epidemiology (MOOSE) group (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283(15):2008–2012
15. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188
16. Clancy C, Burke JP, Barry M, Kalady MF, Calvin Coffey J (2014) A meta-analysis to determine the effect of primary tumor resection for stage IV colorectal cancer with unresectable metastases on patient survival. Ann Surg Oncol 21(12):3900–3908
17. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820–826
18. Clancy C, Burke JP, Coffey JC (2013) KRAS mutation does not predict the efficacy of neo-adjuvant chemoradiotherapy in rectal cancer: a systematic review and meta-analysis. Surg Oncol 22(2):105–111
19. Ali RA, Dooley C, Comber H, Newell J, Egan LJ (2011) Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease. Clin Gastroenterol Hepatol 9(7):584–589 e1-2
20. Bansal P, Sonnenberg A (1996) Risk factors of colorectal cancer in inflammatory bowel disease. Am J Gastroenterol 91(1):44–48
21. Gearhart SL, Nathan H, Pawlik TM, Wick E, Efron J, Shore AD (2012) Outcomes from IBD-associated and non -IBD-associated colorectal cancer: a surveillance epidemiology and end results medicare study. Dis Colon rectum 55(3):270–277
22. Greenstein AJ, Slater G, Heimann TM, Sachar DB, Aufses AH (1986) A comparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli, and de novo cancer. Ann Surg 203(2):123–128
23. Hamilton SR (1985) Colorectal carcinoma in patients with Crohn’s disease. Gastroenterology 89(2):398–407
24. Hughes RG, Hall TJ, Block GE, Levin B, Moossa AR (1978) The prognosis of carcinoma of the colon and rectum complicating ulcerative colitis. Surg Gynecol Obstet 146(1):46–48
25. Hulten L, Kewenter J, Ahren C, Ojerskog B (1979) Clinical and morphological characteristics of colitis carcinoma and colorectal carcinoma in young people. Scand J Gastroenterol 14(6):673–678
26. Kiran RP, Khoury W, Church JM, Lavery IC, Fazio VW, Remzi FH (2010) Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn’s and ulcerative colitis based on three decades of experience. Ann Surg 252(2):330–335
27. Leowardi C, Schneider ML, Hinz U, Harnoss JM, Tarantino I, Lasitschka F, Ulrich A, Büchler MW, Kadmon M (2016) Prognosis of ulcerative colitis-associated colorectal carcinoma compared to sporadic colorectal carcinoma: a matched pair analysis. Ann Surg Oncol 23(3):870–876
28. Ohman U (1982) Colorectal carcinoma in patients with ulcerative colitis. Am J Surg 144(3):344–349
29. Ording AG, Horvath-Puho E, Erichsen R, Long MD, Baron JA, Lash TL, Sørensen HT (2013) Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn’s disease: a nationwide population-based cohort study. Inflamm Bowel Dis 19(4):800–805
30. Renz BW, Thasler WE, Preissler G, Heide T, Khalil PN, Mikhailov M, Jauch KW, Kreis ME, Rentsch M, Kleespies A (2013) Clinical outcome of IBD-associated versus sporadic colorectal cancer: a matched-pair analysis. J Gastrointest Surg 17(5):981–990
31. Ritchie JK, Hawley PR, Lennard-Jones JE (1981) Prognosis of carcinoma in ulcerative colitis. Gut 22(9):752–755
32. Shaukat A, Salfiti NI, Virnig DJ, Howard DH, Sitaraman SV, Liff JM, Lederle FA (2012) Is ulcerative colitis associated with survival among older persons with colorectal cancer in the US? A population-based case-control study. Dig Dis Sci 57(6):1647–1651
33. Shu X, Ji J, Sundquist J, Sundquist K, Hemminki K (2011) Survival in cancer patients hospitalized for inflammatory bowel disease in Sweden. Inflamm Bowel Dis 17(3):816–822
34. Gyde S, Prior P, Dew MJ, Saunders V, Waterhouse JA, Allan RN (1982) Mortality in ulcerative colitis. Gastroenterology 83(1 Pt 1):36–43
35. Risques RA, Lai LA, Himmetoglu C, Ebaee A, Li L, Feng Z, Bronner MP, Al-Lahham B, Kowdley KV, Lindor KD, Rabinovitch PS, Brentnall TA (2011) Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. Cancer Res 71(5):1669–1679
36. Leedham SJ, Graham TA, Oukrif D, McDonald SA, Rodriguez-Justo M, Harrison RF, Shepherd NA, Novelli MR, Jankowski JA, Wright NA (2009) Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia. Gastroenterology 136(2):542–550.e6
37. Ullman TA, Itzkowitz SH (2011) Intestinal inflammation and cancer. Gastroenterology 140(6):1807–1816
38. Bossard C, Denis MG, Bezieau S, Bach-Ngohou K, Bourreille A, Laboisse CL, Mosnier JF (2007) Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis. Oncol Rep 18(5):1093–1097
39. Burmer GC, Rabinovitch PS, Haggitt RC, Crispin DA, Brentnall TA, Kolli VR, Stevens AC, Rubin CE (1992) Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology 103(5):1602–1610
40. Juni P, Altman DG, Egger M (2001) Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323(7303):42–46